Inventor · disambiguated record
Houman Ashrafian
Also filed as: ASHRAFIAN HOUMAN
4 granted patents·5 pending applications·18 citations·filing 2009–2019
70Inventor score
Files withZARODEX THERAPEUTICS LTD3ASHRAFIAN HOUMAN2HEART METABOLICS LTD2ISIS INNOVATION1UNIV BIRMINGHAM1
Top patents by PatentIndex Score
9 records- 0183US8697728B2Perhexiline for use in the treatment of hypertrophic cardiomyopathy (HCM)ASHRAFIAN HOUMAN·Filed 2010·Granted Apr 15, 2014·13 cites·18 claims
- 0277US8440697B2Treatment of heart failureASHRAFIAN HOUMAN·Filed 2010·Granted May 14, 2013·5 cites·5 claims
- 0359US2010008908A1Treatment of Heart FailureISIS INNOVATION·Filed 2009·Application pending·0 cites
- 0454US9468634B2Treatment of heart failureHEART METABOLICS LTD·Filed 2013·Granted Oct 18, 2016·0 cites·13 claims
- 0554US9457017B2Treatment of heart failureHEART METABOLICS LTD·Filed 2013·Granted Oct 4, 2016·0 cites·23 claims
- 0648US2014194466A1Perhexiline for use in the treatment of hypertrophic cardiomyopathy (hcm)UNIV BIRMINGHAM·Filed 2014·Application pending·0 cites
- 0733US2021236513A1Novel usesZARODEX THERAPEUTICS LTD·Filed 2019·Application pending·0 cites
- 0833US2021236512A1Clozapine for the treatment of a immunoglobulin driven b cell diseaseZARODEX THERAPEUTICS LTD·Filed 2019·Application pending·0 cites
- 0933US2021137941A1Clozapine for the treatment of ig-e driven b cell diseasesZARODEX THERAPEUTICS LTD·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Houman Ashrafian files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →